Serum sclerostin levels were significantly elevated in the sarcopenia group (158 ± 52.4 vs. 126 ± 75.7 pg/mL, p = 0.036), and regarding BMD, no significant group differences were observed for most regions. The gene discussed is SOST; the disease is sarcopenia.